Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
复制标题

DOI:
10.1172/jci31911
复制
发表时间:
2007-09-01
影响因子:
15.9
通讯作者:
Munn, David H.
Munn, David H.
中科院分区:
医学1区
文献类型:
--
作者:
Sharma, Madhav D.;Baban, Babak;Munn, David H.

文献摘要

被引文献

相似文献

在小鼠肿瘤清除的LNS中,少量的浆细胞样树突状细胞(PDC)可以表达免疫调节酶吲哚胺2,3-双加氧酶(IDO)。我们发现这些IDO+pDC可以直接激活静息的CD4(+)CD25(+)Foxp3(+)树突状细胞,以达到有效的抑制活性。在体内,从肿瘤引流的淋巴结中分离出的Tregs在体外立即被结构性地激活和抑制抗原特异性T细胞。在体外,来自肿瘤引流的LNS的IDO+pDC可以快速激活非荷瘤宿主的静息Tregs,而不需要丝裂原或外源抗CD3交联剂。IDO+pDC对Treg的激活受到MHC的限制,需要Tregs中完整的氨基酸反应GCN2通路,并被CTLA4阻断。经IDO激活的Tregs可显著上调靶DC上PD-L1和PD-L2的表达,其抑制靶T细胞增殖的能力可被抗程序性细胞死亡1/PD-L(PD-1/PD-L)通路的抗体所阻断。相反,抗CD3交联剂激活的Treg不会引起PD-LS的上调,并且这些细胞的抑制不会通过阻断PD-1/PD-L通路而受到影响。从体内肿瘤引流的淋巴结中分离到的Tregs具有很强的PD-1/PD-L介导的抑制作用,当肿瘤生长在IDO缺乏的宿主中时,这种抑制作用被选择性地丧失。我们假设IDO+PDCs通过Tregs的结构性激活在肿瘤引流的LNS内创造了一个深刻的抑制微环境。
A small population of plasmacytoid DCs (pDCs) in mouse tumor-draining LNs can express the immunoregulatory enzyme indoleamine 2,3-dioxygenase (IDO). We show that these IDO+ pDCs directly activate resting CD4(+)CD25(+)Foxp3(+) Tregs for potent suppressor activity. In vivo, Tregs isolated from tumor-draining LNs were constitutively activated and suppressed antigen-specific T cells immediately ex vivo. In vitro, IDO+ pDCs from tumor-draining LNs rapidly activated resting Tregs from non-tumor-bearing hosts without the need for mitogen or exogenous anti-CD3 crosslinking. Treg activation by IDO+ pDCs was MHC restricted, required an intact amino acid-responsive GCN2 pathway in the Tregs, and was prevented by CTLA4 blockade. Tregs; activated by IDO markedly upregulated programmed cell death 1 ligand 1 (PD-L1) and PD-L2 expression on target DCs, and the ability of Tregs to suppress target T cell proliferation was abrogated by antibodies against the programmed cell death 1/PD-L (PD-1/PD-L) pathway. In contrast, Tregs activated by anti-CD3 crosslinking did not cause upregulation of PD-Ls , and suppression by these cells was unaffected by blocking the PD-1/PD-L pathway. Tregs isolated from tumor-draining LNs in vivo showed potent PD-1/PD-L-mediated suppression, which was selectively lost when tumors were grown in IDO-deficient hosts. We hypothesize that IDO+ pDCs create a profoundly suppressive microenvironment within tumor-draining LNs via constitutive activation of Tregs.